Can I Take Magnesium With Spironolactone?

Spironolactone (brand names Aldactone and CaroSpir) is an FDA-approved aldosterone antagonist and potassium-sparing diuretic, approved for conditions such as heart failure, hypertension, and edema. Its use for hormonal acne, hirsutism, and PCOS-related androgenic symptoms is off-label but common in dermatology practice. Magnesium is an over-the-counter dietary mineral supplement sold in several chemical forms (glycinate, citrate, oxide, malate, chloride), each with different absorption characteristics.

There is no known pharmacokinetic drug interaction between spironolactone and magnesium. The two do not compete for the same metabolic enzymes, and magnesium does not measurably change spironolactone blood levels or vice versa. The interaction that matters is pharmacodynamic and physiological: spironolactone blocks aldosterone, which has a modest magnesium-retaining side effect layered on top of its much larger potassium-retaining effect. In a person with normal kidney function taking a standard over-the-counter magnesium dose, this is not expected to cause a clinically important rise in serum magnesium. In a person with reduced kidney function, high-dose magnesium, or other drugs that also affect magnesium and potassium handling, the combination needs a clinician's input rather than self-management.

The useful question for most readers is not "does magnesium interact with spironolactone" but "does my kidney function, dose, and drug list put me in the group that needs a lab check before combining them."

Why This Combination Comes Up So Often

Magnesium is one of the most commonly used dietary supplements in the United States, and many adults do not meet the recommended dietary allowance from food alone, according to the National Institutes of Health Office of Dietary Supplements. (NIH ODS Magnesium fact sheet)

Spironolactone is widely prescribed off-label for hormonal acne, hirsutism, and PCOS symptoms, largely in women of reproductive age, a population that also has a high rate of magnesium supplement use for reasons unrelated to acne, including premenstrual symptoms, sleep, and migraine. The overlap between the two medication lists is common, which is why the interaction question comes up in dermatology and primary care visits rather than being a rare edge case.

How Spironolactone Affects Electrolytes

Spironolactone blocks the mineralocorticoid receptor in the distal nephron. Blocking aldosterone's action reduces sodium reabsorption and reduces potassium excretion, which is the mechanism behind its "potassium-sparing" classification and its labeled warning about hyperkalemia. This mechanism is well described in standard pharmacology references for spironolactone (Aldactone).

Magnesium is handled differently in the kidney, with most reabsorption occurring in the thick ascending limb of the loop of Henle rather than the distal segments spironolactone acts on. Aldosterone has a secondary, smaller magnesium-wasting effect in the distal nephron, so blocking aldosterone is physiologically plausible as a mild magnesium-retaining influence. This mechanism is well established in renal physiology, but the magnitude of the effect at acne-relevant spironolactone doses (25 to 100 mg/day) has not been quantified in dedicated interaction studies that we can point to with confidence. That gap should be stated plainly rather than filled with a specific number.

What is established: spironolactone reduces potassium excretion through a well-described receptor mechanism, and this effect is much larger and better documented than any magnesium effect. What is plausible but not demonstrated with a precise figure in this population: a small, aldosterone-mediated reduction in magnesium excretion at typical acne dosing. What is not established: any specific serum magnesium change (in mg/dL or mEq/L) that a reader should expect from adding a standard OTC magnesium supplement to spironolactone 50 to 100 mg/day.

Is There a Direct Drug Interaction?

No CYP450 enzyme shared between spironolactone metabolism and magnesium absorption has been identified, and there is no established mechanism by which oral magnesium would meaningfully change spironolactone's active metabolite levels (canrenone and 7-alpha-thiomethylspironolactone). Spironolactone's oral bioavailability improves when taken with food, which is a reason to take it with meals; this is a food-effect, not a magnesium-effect, and no specific dose-separation window between spironolactone and magnesium is supported by available pharmacology.

Magnesium's own absorption varies substantially by chemical form: oxide has the lowest absorbed fraction and the highest rate of GI side effects at higher doses, while glycinate, malate, and citrate are generally better tolerated. These absorption differences are described in the NIH ODS fact sheet and are relevant to dosing decisions independent of spironolactone. (NIH ODS Magnesium fact sheet)

The Real Risk: Hypermagnesemia, and Who Is Actually at Risk

Hypermagnesemia (an elevated serum magnesium) is rare in people with normal kidney function, because intact kidneys excrete excess magnesium efficiently. The risk rises meaningfully in a smaller group of patients:

• Chronic kidney disease, especially eGFR below 45 to 60 mL/min/1.73m², where magnesium clearance falls with GFR
• Concurrent use of other magnesium-containing products taken regularly, such as magnesium hydroxide antacids or magnesium citrate used as a laxative
• Magnesium doses well above the NIH Tolerable Upper Intake Level for supplements (350 mg elemental magnesium/day for adults, from non-food sources) (NIH ODS Magnesium fact sheet)
• Heart failure or other states of reduced renal perfusion, where spironolactone is often used at higher doses than for acne and where electrolyte monitoring is already part of standard care

Symptoms of hypermagnesemia generally progress from nausea, flushing, and headache at modest elevations to diminished reflexes and neuromuscular slowing at higher levels, with cardiac conduction effects at more severe elevations. Most outpatients on spironolactone plus a standard OTC magnesium dose do not approach these levels, but anyone with new muscle weakness, palpitations, or unexplained fatigue while on both should have it evaluated rather than assumed to be benign.

If you have reduced kidney function, heart failure, or take another magnesium-containing product regularly, ask your prescriber for a basic metabolic panel and serum magnesium before adding a supplement, rather than starting on your own.

Hypomagnesemia and Potassium: The More Common Practical Issue

A separate and arguably more common clinical issue is not spironolactone-plus-magnesium raising magnesium too high, but underlying magnesium deficiency (common with low dietary intake, alcohol use, or gastrointestinal losses) impairing the cellular machinery that keeps potassium inside cells. Magnesium is a required cofactor for the Na/K-ATPase pump, and magnesium deficiency is a recognized contributor to refractory hypokalemia in the nephrology literature, meaning potassium repletion can be difficult to achieve until magnesium is corrected. This is a well-established physiological relationship, though the exact prevalence figures vary between studies and should not be quoted as a precise universal number without checking the specific source.

For a patient on spironolactone who is also genuinely magnesium-deficient, correcting that deficiency with a modest supplement dose is not automatically a risk; it may support the same electrolyte stability that spironolactone is meant to help maintain. This is a reason clinicians may recommend magnesium alongside spironolactone rather than a reason to avoid it, but the decision still depends on the patient's kidney function and other medications.

Choosing a Magnesium Form

Absorption and tolerability differ meaningfully across forms, which matters more once spironolactone is in the picture because a spike in absorbed magnesium is more relevant in anyone with reduced renal clearance.

• Magnesium glycinate: relatively well absorbed, generally well tolerated with minimal laxative effect, and a common first choice for supplementation alongside spironolactone
• Magnesium malate: reasonably well absorbed; sometimes chosen when fatigue symptoms are also present, though this use case is separate from the spironolactone question
• Magnesium citrate: moderately absorbed but prone to loose stools at higher doses, which limits how much can practically be taken
• Magnesium oxide: poorly absorbed and the form most associated with GI side effects and dose escalation by patients trying to get an effect; not the preferred choice when a steady, modest dose is the goal
• Magnesium chloride (liquid): efficiently absorbed and capable of a faster serum rise, which is a consideration in anyone with even mild renal impairment

Staying at or below the NIH Tolerable Upper Intake Level of 350 mg elemental magnesium/day from supplements is a reasonable general guardrail for adults with normal kidney function who are also on spironolactone, recognizing that dietary magnesium from food is not counted against this limit because gut absorption from food is more tightly regulated. (NIH ODS Magnesium fact sheet)

Evidence-Status Interaction Assessment

Use this table to see which parts of the spironolactone-magnesium question are backed by established mechanism or regulatory guidance, which are physiologically plausible but not precisely quantified, and which require a clinician or pharmacist check before acting.

Verify before relying on: any specific quantitative claim about serum magnesium change, exact percentages from named trials, or a direct quotation attributed to a guideline body. Several precise figures that circulate on this topic (trial sample sizes, exact percentage reductions, direct quotes from guideline text) could not be confirmed against a specific, checkable primary source for this draft and have been removed or hedged rather than repeated as fact. A pharmacist or the prescribing clinician can confirm current guideline wording and any patient-specific lab targets.

Practical Guidance

1. Get a baseline basic metabolic panel (sodium, potassium, creatinine, BUN, glucose) when spironolactone is started; this is already standard practice for most prescribers regardless of supplement use.
2. If you plan to add magnesium, ask whether a baseline serum magnesium and eGFR should be checked, particularly if you have any degree of kidney disease, heart failure, or diabetes, or take another magnesium-containing product regularly.
3. Choose a well-absorbed, well-tolerated form (glycinate or malate) over magnesium oxide, and stay at or below 350 mg elemental magnesium/day from supplements unless a clinician has advised otherwise.
4. Take both with food; this improves spironolactone's absorption and reduces magnesium-related GI upset. No specific separation window is required between the two.
5. Recheck labs at a follow-up visit (commonly 6 to 8 weeks after starting or changing either medication), and sooner if you develop nausea, flushing, muscle weakness, palpitations, or unusual fatigue.
6. Tell your prescriber about all supplements, including magnesium-containing antacids or laxatives, since these add an unpredictable and sometimes forgotten magnesium load.
7. If you have heart failure, CKD, or are on an ACE inhibitor, ARB, or another agent that also affects potassium or magnesium, do not self-direct magnesium dosing; this combination needs individualized clinician oversight.

When to Seek Urgent Care

Seek prompt medical attention if you are taking spironolactone and develop muscle weakness, irregular heartbeat, confusion, or significant fatigue, especially if you also take magnesium supplements, magnesium-containing laxatives or antacids, or have known kidney disease. These can be signs of a significant electrolyte disturbance (high potassium or high magnesium) that needs same-day evaluation rather than a routine follow-up appointment.